AQR CAPITAL MANAGEMENT LLC 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-13 1:39 pm Sale | 2026-06-30 | 13G | SAREPTA THERAPEUTICS INC SRPT | AQR CAPITAL MANAGEMENT LLC | 5,329,691 5.050% | -2,775,178 (-34.24%) | Filing |
| 2026-02-13 11:52 am Purchase | 2025-12-31 | 13G | SAREPTA THERAPEUTICS INC SRPT | AQR CAPITAL MANAGEMENT LLC | 8,104,869 7.730% | 8,104,869 (New Position) | Filing |